Kodein Fmk (Codeine Phosphate Hemihydrate)

Codeine phosphate binds to µ‑opioid receptors in the brain and spinal cord, reducing the perception of pain and diminishing the cough reflex. Its metabolites, produced by liver enzymes, enhance these central effects by further modulating neuronal signaling.

The appropriate dose of Kodein Fmk is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Dosage instructions are individualized and should be followed exactly as written on the prescription label.

Safety of codeine phosphate in pregnancy and lactation is not fully established. Healthcare providers generally avoid opioid use unless the benefit outweighs potential risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To request Kodein Fmk, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with non‑opioid antitussives such as dextromethorphan, codeine phosphate provides stronger central cough suppression but carries a higher risk of opioid‑related side effects and dependence. Selection depends on the severity of cough, patient risk factors, and clinical judgment.

Kodein Fmk should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Kodein Fmk is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal upset. Follow the prescribing clinician’s instructions regarding timing and frequency.

The most serious risks include respiratory depression, especially in patients with compromised breathing, severe allergic reactions, and the potential for dependence, abuse, or overdose. Patients should be monitored closely for signs of these events, and emergency medical help should be sought if they occur.

Kodein Fmk is contraindicated in individuals with known hypersensitivity to codeine or other opioids, those with severe respiratory depression, acute or severe asthma, and patients who have taken MAO inhibitors within the past 14 days. It should also be avoided in children unless specifically prescribed by a pediatric specialist.